Dr. Yardley Offers Advice to Community Oncologists on Managing Patients
Denise Yardley, MD, Senior Investigator, Sarah Cannon Research Institute, offers advice to community oncologists on managing patients.
Denise Yardley, MD, Senior Investigator, Sarah Cannon Research Institute, offers advice to community oncologists on managing patients.
The management of patients is a continual moving target, and the challenge is staying in tune with the new developments, Yardley says. It is also important to counsel patients on the role of clinical trials, and offer them appropriate clinical trial opportunities.
There has been an explosion of new and novel drugs and targets as a result of patients and physicians communicating about clinical trial opportunities, Yardley says.
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
September 25th 2020In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Listen
HER2-Low and -Ultralow Populations Benefit from T-DXd in HR+ mBC
November 13th 2024During a Case-Based Roundtable® event, Aditya Bardia, MD, MS, FASCO, discussed data from the DESTINY-Breast04 and DESTINY-Breast06 trials for HER2-low breast cancer in the second article of a 2-part series.
Read More
